Hepatitis B News and Research

Latest Hepatitis B News and Research

Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

Countries in Asia Pacific are unlikely to meet their commitment to eliminate hepatitis by 2030 unless they declare a public health emergency, as they did with COVID-19, a disease specialist suggested.

1 Jul 2024

Human milk banks improve infant health but can't fully replace mother's milk

Scientists investigate human milk banks and their impact on infant health, highlighting differences between donated and maternal milk in gut microbiota and development.

25 Jun 2024

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in patients with diabetic retinopathy (DR).

2 Jun 2024

FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men

The federal government in 2020 and 2023 changed who it said could safely donate organs and blood, reducing the restrictions on men who have had sex with another man.

24 May 2024

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year, according to a new WHO report - Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030.

22 May 2024

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.

9 May 2024

50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives

The World Health Organization’s Expanded Programme on Immunization (EPI) has prevented 154 million deaths since 1974, significantly reducing global infant mortality and contributing 10.2 billion years of healthy life due to vaccinations.

7 May 2024

Study reveals global underassessment and undertreatment of chronic hepatitis B

New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of Hepatology, published by Elsevier, details.

2 May 2024

154 million lives saved: Landmark study highlights power of vaccination

A major landmark study to be published by The Lancet reveals that global immunization efforts have saved an estimated 154 million lives – or the equivalent of 6 lives every minute of every year – over the past 50 years.

25 Apr 2024

Paclitaxel treatment found to directly promote HBV replication and transcription

Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy.

24 Apr 2024

Study identifies molecular pathway in liver cancer development

As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths.

23 Apr 2024

Canada unlikely to eliminate Hepatitis C by 2030, study finds

Canada will not reach the original World Health Organization's (WHO) target of eliminating the Hepatitis C virus (HCV) by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University of Waterloo has found.

15 Apr 2024

Novel immune cell therapy may be a promising strategy for combating HBV infection

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Researchers investigated the link between non-alcoholic fatty liver disease in individuals with type 2 diabetes mellitus (T2DM) and all-cause death and cardiovascular disease.

16 Feb 2024

Hepatitis B News and Research

Latest Hepatitis B News and Research

Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

Human milk banks improve infant health but can't fully replace mother's milk

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives

Study reveals global underassessment and undertreatment of chronic hepatitis B

154 million lives saved: Landmark study highlights power of vaccination

Paclitaxel treatment found to directly promote HBV replication and transcription

Study identifies molecular pathway in liver cancer development

Canada unlikely to eliminate Hepatitis C by 2030, study finds

Novel immune cell therapy may be a promising strategy for combating HBV infection

Second-generation melanoma vaccine prolongs survival of patients with skin cancer

West Virginia city once battered by opioid overdoses confronts ‘fourth wave’

Metal organic frameworks enhance immune response in experimental vaccine

Researchers examine the immune response of a hypervaccinated individual

Nomogram could be a game-changer for predicting alcohol-related liver cancer risk

Machine learning model to determine associations between metabolic syndrome and lactation

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hepatitis B News and Research

Latest Hepatitis B News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in